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ORIGINAL ARTICLE
Onychomycosis Due to Nondermatophytic Molds
Sung Min Hwang, M.D., Moo Kyu Suh, M.D., Gyoung Yim Ha, M.D.
1
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Background: Although there have been many studies about 
onychomycosis due to nondermatophytic molds (NDM), 
few studies about etiologic agents including NDM in 
onychomycosis have been reported in Korea. Objective: 
This study investigated onychomycosis due to NDM in the 
Gyeongju area of Korea. Methods: In the 10-year period from 
1999∼2009, we reviewed 59 patients with onychomycosis 
due to NDM. The etiologic agents were identified by cultures 
on Sabouraud‘s Dextrose agar with and without cyclo-
heximide. In some cases, internal transcribed spacer 
sequence analysis was done. NDM isolated considered 
pathogens when the presence of fungal elements was 
identified by direct microscopy observation and in follow-up 
cultures yielding the same fungi. Results: Onychomycosis 
due to NDM comprised 2.3% of all onychomycosis. Of the 
59 patients with onychomycosis due to NDM, 84.7% were 
toenail onychomycosis and 15.3% were fingernail onycho-
mycosis. The incidence rate was highest in the fifth decade 
(27.1%). The ratio of male to female patients was 1：1.6. The 
frequency of associated diseases, in descending order, was 
hypertension, diabetes mellitus, and cerebral hematoma. 
Distal and lateral subungual onychomycosis (86.4%) was 
the most common clinical type of onychomycosis. 
Aspergillus spp. was the most frequently isolated etiologic 
agent of onychomycosis due to NDM (83.0%). Other 
causative agents were Scopulariopsis brevicaulis (10.2%), 
Acremonium  spp. (3.4%), Fusarium solani (1.7%), and 
Chaetomium globosum (1.7%). Conclusion: Because of the 
increase in onychomycosis due to NDM, we suggest the 
need of a careful mycological examination in patients with 




Onychomycosis denotes any nail infection due to derma-
tophytes, nondermatophytic molds (NDM), or yeasts. The 
increasing prevalence of this disease may be secondary to 
tight shoes, increasing numbers of immunosuppressed 
individuals, and increased used of communal locker 
rooms
1.
NDM are filamentous fungi that are commonly found in 
nature as saprophytes and plant pathogens. Because these 
molds are not keratolytic, unlike dermatophytes, they only 
live on unkeratinized intercellular cement or must take 
advantage of previous keratin destruction by dermatophytes, 
trauma, or another nail disease. For this reason, the inci-
dence of onychomycosis due to NDM is 1.45∼17.6%, 
which is lower than that caused by dermatophytes
2,3. 
NDM causing onychomycosis include Scopulariopsis 
brevicaulis, Aspergillus species, Fusarium species, Sytalidium 
species, and Onychocola canadiensis
1-7.
There have been numerous case reports describing 
onychomycosis due to S. brevicaulis
8,9,  Aspergillus 
species
10-12, and Fusarium species
13,14. However, onycho-
mycosis due to NDM has only been described in one 
study to date
15. Therefore, this study was designed to 
investigate clinical features and isolated pathogens of 
patients with onychomycosis due to NDM in the 10-year 
period from 1999∼2009. A brief review of the literature 
has been included.SM Hwang, et al
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Fig. 1. Annual incidence of patients with onychomycosis due 
to nondermatophytic molds.
Fig. 2. Monthly distribution of patients with onychomycosis due
to nondermatophytic molds.
MATERIALS AND METHODS
Study subjects  
This study included 59 patients who clinically showed 
onychomycosis and were diagnosed with onychomycosis 
due to NDM by 15% potassium hydroxide (KOH) test and 
fungus culture at the Department of Dermatology, Dongguk 
University Gyeongju Hospital during the 10-year period 
from July 1999 to June 2009. Of these patients, 50 




The medical records of the 59 patients were retro-
spectively analyzed in terms of clinical features, yearly/ 
monthly/seasonal variations in incidence, age, sex, 
associated disease, sites of nail involvement, and clinical 
type. According to the classification of Baran et al.
16, we 
classified onychomycosis into five clinical types: distal 
and lateral subungual onychomycosis (DLSO), superficial 
white onychomycosis (SWO), proximal subungual onycho-
mycosis (PSO), endonyx onychomycosis (EO), and total 
dystrophic onychomycosis (TDO).
2) Fungus test, fungus culture, and identification of 
causative pathogens
After the nail was sterilized with 75% alcohol, we 
obtained the sample by scraping the hyperkeratotic nail 
bed with a disposable scalpel. Nail samples were micro-
scopically studied after clearing for 30 minutes in 15% 
KOH. For cultures, each specimen was inoculated in three 
sites on Sabouraud’s Dextrose agar (SDA) with and without 
0.5 mg/ml cyclohexamide and incubated at room 
temperature for 2∼4 weeks. Causative pathogens were 
identified based on gross and microscopic findings of 
colonies. In cases where this identification was not obvious, 
the pathogens were identified by analyzing the base 
sequence of the internal transcribed spacer (ITS) region. 
Onychomycosis due to NDM was defined according to a 
modification of a previously described method
17, when 
the 15% KOH test was positive, three or more identical 
colonies were found in fungus cultures, and the identical 
fungi were identified in repeated fungus cultures.
RESULTS
Yearly variations in incidence
The total number of patients with onychomycosis during 
the study period was 2,584. Of these patients, 59 showed 
onychomycosis due to NDM accounting for 2.3% of all 
onychomycosis cases. The incidence onychomycosis due 
to NDM was highest during the period between July 2000 
and June 2001 (n=11, 18.6%) and lowest during the 
period between July 2007 and June 2008 (n=2, 3.4%) 
(Fig. 1).
Monthly and seasonal variations in incidence
In decreasing order of frequency, 10 patients developed 
onychomycosis due to NDM in February; nine patients in 
July; six patients in October; five patients each in January, 
March, June, and December; four patients each in April 
and August; three patients in May; two patients in 
November; and one patient in September. Twenty patients 
developed onychomycosis due to NDM during the winter 
(December through February), 18 patients during the 
summer (June through August), 12 patients during the Onychomycosis Due to Nondermatophytic Molds
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Table 1. Age and sex distribution in patients with onychomycosis
due to nondermatophytic molds
Age (yr)/Sex Male Female Total
 0 ∼9 −−−
10∼19 −−−
20∼29 −−−
30∼39  5 (21.7) 3 (8.3)  8 (13.6)
40∼49  7 (30.4)  9 (25.0) 16 (27.1)
50∼59  6 (26.1)  8 (22.2) 14 (23.7)
60∼69  4 (17.4) 10 (27.8) 14 (23.7)
70∼79 1 (4.3)  5 (13.9)  6 (10.2)
80∼89 - 1 (2.8) 1 (1.7)
Total 23 (39.0) 36 (61.0)  59 (100.0)
Values are presented as n (%).
Table 2. Associated diseases in patients with onychomycosis due
to nondermatophytic molds
Associated diseases Patients, n=59
  Hypertension 5 (8.5)
  DM+Hypertension 4 (6.8)
  DM 3 (5.1)
  DM+Hyperthyroidism 1 (1.7)
  Cerebral hematoma 2 (3.4)
  Cerebral infarction 1 (1.7)
  Breast carcinoma 1 (1.7)
  Chronic renal failure 1 (1.7)
  Congestive heart failure 1 (1.7)
  Pulmonary tuberculosis 1 (1.7)
  Total 20 (33.9)
Values are presented as n (%). DM: diabetes mellitus.









other nail 1∼2 3∼4 5∼6 7∼8 9∼10
  Toenail 14 35 1 50 17 9 12 4 8
  Fingernail 6 2 1 9 6 3 −−−
Values are number of patients.
spring (March through May), and nine patients during the 
fall (September through November); however, the differences 
were not significant (Fig. 2).
Age and sex
Onychomycosis due to NDM occurred most commonly in 
patients in their 40s (27.1%), followed by those between 
their 50s and 60s (23.7%), and those in their 30s (13.6%). 
Overall, onychomycosis occurred frequently in patients 
between their 40s and 60s (Table 1). The male to female 
ratio was 1 : 1.6, with a predilection for females (23 males 
and 36 females) (Table 1). 
Associated disease
Twenty (33.9%) of the 59 patients with onychomycosis 
due to NDM had concurrent diseases. Hypertension was 
most common (15.3%), followed by diabetes mellitus 
(n=8, 13.6%), cerebrovascular accidents (n=2, 3.4%), 
hyperthyroidism (n=1, 1.7%), cerebral infarction (n=1, 
1.7%), breast cancer (n=1, 1.7%), chronic renal failure 
(n=1, 1.7%), congestive heart failure (n=1, 1.7%), and 
pulmonary tuberculosis (n=1, 1.7%) (Table 2).
Sites of nail involvement
Of the 59 patients with onychomycosis due to NDM, 50 
(84.7%) had toenail onychomycosis alone and nine 
(15.3%) had fingernail onychomycosis alone. Of the 50 
patients with toenail onychomycosis, 14 (28.0%) showed 
involvement of the first toenail alone and 35 (70%) 
showed involvement of multiple toenails including the 
first toenail. Of the nine patients with fingernail onycho-
mycosis, six (66.7%) showed involvement of the first 
fingernail alone and two (22.2%) showed involvement of 
multiple fingernails including the first fingernail. The 
number of involved toenails was one or two in 17 patients 
(34.0%), five or six in 12 patients (24.0%), three or four in 
nine patients (18.0%), nine or 10 in eight patients (16.0%), 
and seven or eight in four patients (8%). The number of 
involved fingernails was one or two in six patients 
(66.7%), followed by three or four in three patients 
(33.3%). There were no patients with involvement of ≥5 
fingernails (Table 3).
Clinical type
As for the clinical type of toenail onychomycosis due to 
NDM, DLSO was most common (n=46, 92.0%), followed 
by TDO (n=2, 4.0%), SWO (n=1, 2.0%) and PSO (n=1, 
2.0%). As for the clinical type of fingernail onychomycosis 
due to NDM, DLSO was found in five patients (55.6%) 
and PSO in four patients (44.4%). Overall, DLSO was 
most common (n=51, 86.4%), followed by PSO (n=5, 
8.5%), TDO (n=2, 3.4%), and SWO (n=1, 1.7%) (Table 4).SM Hwang, et al
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Table 4. Classification of onychomycosis due to NDM according







  DLSO 46 (92.0) 5 (55.6) 51 (86.4)
  SWO 1 (2.0) − 1 (1.7)
  PSO 1 (2.0) 4 (44.4) 5 (8.5)
  TDO 2 (4.0) − 2 (3.4)
  Total 50 (84.7) 9 (15.3) 59 (100)
Values are presented as n (%). NDM: nondermatophytic molds,
DLSO: distal and lateral subungual onychomycosis, SWO: 
superficial white onychomycosis, PSO: proximal subungual 
onychomycosis, TDO: total dystrophic onychomycosis. 
Table 6. Classification of onychomycosis due to NDM according to the clinical types and isolated fungi 
Species
DLSO SWO PSO TDO
TN FN TN FN TN FN TN FN
Aspergillus niger 14 1 1 −−41 −
Aspergillus fumigatus 13 2 −−−− −−
Aspergillus flavus  81 −−−− −−
Aspergillus terreus  11 −−−− 1 −
Aspergillus sydowii  1 −− −− −− −
Scopulariopsis brevicaulis  5 −− −1 −− −
Acremonium  species  2 −− −− −− −
Fusarium solani  1 −− −− −− −
Chaetomium globosum  1 −− −− −− −
NDM: nondermatophytic molds, DLSO: distal and lateral subungual onychomycosis, SWO: superficial white onychomycosis, PSO: 
proximal subungual onychomycosis, TDO: total dystrophic onychomycosis, TN: toenails, FN: fingernails.




Toenail onychomycosis Fingernail onychomycosis
Aspergillus niger 16 (32.0) 5 (55.6) 21 (35.6)
Aspergillus fumigatus 13 (26.0) 2 (22.2) 15 (25.4)
Aspergillus flavus  8 (16.0) 1 (11.1)  9 (15.3)
Aspergillus terreus  2 (4.0) 1 (11.1) 3 (5.1)
Aspergillus sydowii  1 (2.0) − 1 (1.7)
Scopulariopsis brevicaulis  6 (12.0) −  6 (10.2)
Acremonium  species  2 (4.0) − 2 (3.4)
Fusarium solani  1 (2.0) − 1 (1.7)
Chaetomium globosum  1 (2.0) − 1 (1.7)
Total 50 (84.7) 9 (15.3)  59 (100.0)
Values are presented as n (%).
Isolated causative pathogens
The colonies of NDM were observed on two SDA plates 
without cycloheximide slants at 25
oC for 2 weeks. But, 
there was no growth of NDM and dermatophytes on SDA 
with cycloheximide slants. 
Of the causative organisms with toenail onychomycosis 
due to NDM, Aspergillus  species were most commonly 
isolated (40/50, 80.0%), followed by S. brevicaulis (6/50, 
12.0%),  Acremonium species (2/50, 4.0%), F. solani 
(1/50, 2.0%), and C. globosum (1/50, 2.0%). Of the 
Aspergillus species, A. niger was the most common orga-
nism (16/50, 32.0%), followed by A. fumigatus (13/50, 
26.05), A. flavus (8/50, 16.0%), A. terreus (2/50, 4.0%), 
and A. sydowii (1/50, 2.0%). In our patients with finger-
nail onychomycosis due to NDM, only Aspergillus species 
was isolated; A. niger was most commonly isolated (5/9, 
55.6%), followed by A. fumigatus (2/9, 22.2%), A. flavus 
(1/9, 11.1%), and A. terreus (1/9, 11.1%). Overall, Asper-
gillus species was most commonly isolated (49/59, 
83.0%), followed by S. brevicaulis (96/59, 10.2%), Acre-
monium species (2/59, 3.4%), F. solani (1/59, 1.7%), and 
C. globosum (1/59, 1.7%). A. niger was most commonly 
isolated (21/59, 35.6%), followed by A. fumigatus (15/59, 
25.4%), A. flavus (9/59, 15.3%), A. terreus (3/59, 5.1%), 
and A. sydowii  (1/59, 1.7%) (Table 5). Of the 49 Aspergillus- 
related cases, DLSO was most common (n= 42), followed 
by PSO (n=4), TDO (n=2), and SWO (n= 1). Of the 21 
A. niger strains alone, DLSO was most common (n=15), Onychomycosis Due to Nondermatophytic Molds
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followed by PSO (n=4), SWO (n=1), and TDO (n=1). Of 
the three A. terreus strains alone, DLSO was found in two 
cases and TDO was found in one case. One A. sydowii 
strain showed DLSO. Of the six S. brevicaulis strains 
alone, DLSO was found in five cases and PSO was found 
in one case. Both of the two strains of the Acremonium 
species showed DLSO. One F. solani strain and one C. 
globosum showed DLSO (Table 6). 
DISCUSSION
Medically confirmed onychomycosis should be treated. 
This recommendation is based on several disease-specific 
considerations: cosmetic and functional disability, lack of 
spontaneous remission, impairment of health and well-
being in elderly patients, and the need to reduce con-
tamination in communal bathing places
18. Treatment of 
onychomycosis due to NDM requires more time than 
treatment of those with onychomycosis due to derma-
tophytes, and some patients with onychomycosis due to 
NDM frequently do not respond to antifungal agents
2,6,9-23. 
This study was performed because the incidence of 
onychomycosis due to NDM has recently increased
3,6,24. 
In this study, onychomycosis due to NDM accounted for 
2.3% of all onychomycosis cases, which falls within the 
reported prevalence between 1.45% and 17.6%. Most of 
the reported incidences are higher than the present 
figure
1-6,25. However, the incidence reported by Bonifaz et 
al.
7 (1.49%) was lower than the present figure. The 
incidence was highest between July 2000 and June 2001, 
but there was no increasing tendency. There was no 
significant difference in monthly and seasonal incidence. 
Onychomycosis due to NDM most frequently occurred in 
subjects in their 40s (26.2%) and was prevalent in subjects 
between their 30s and 60s (84.7%), which are similar to 
the previous
2,7. The male to female ratio was 1：1.6 with 
a predilection for females, consistent with previous 
results
2,5. 
In this study, concurrent diseases were found in 33.9% of 
patients. Hypertension was the most common concurrent 
disease (15.3%), followed by diabetes mellitus. Systemic 
diseases, such as diabetes mellitus, frequently cause 
onychomycosis
26,27. However, onychomycosis due to 
NDM is not necessarily associated with systemic diseases
2. 
In this study, toenail onychomycosis accounted for 84.7% 
of all cases of onychomycosis, which is lower than the 
results reported by Bonifaz et al.
7 (96.2%) and Tosti et al.
2 
(89.7%), but higher than those reported by Hilmioğlu- 
Polat et al.
5 (67.0%) and Gianni et al.
6 (67.0%). 
In our study, DLSO was found in 86.4% of patients, which 
was consistent with the results reported by Bonifaz et al.
7. 
However, Tosti et al.
2 and Moreno and Arenas
3 reported 
that PSO with periungual inflammation was 64.4% and 
76.0%, respectively. PSO was found in 44.4% of our 
patients with fingernail onychomycosis. Further studies on 
clinical types in fingernail onychomycosis are required. 
In our patients with onychomycosis due to NDM, Asper-
gillus species were most frequently isolated (83.0%), 
which is consistent with the results reported by Bassiri- 
Jahromi and Khaksar,
4 Hilmioğlu-Polat et al.
5, Gupta et 
al.
28 and Ramani et al.
29. The second most commonly 
isolated fungi were S. brevicaulis (10.2%), Acremonium 
species (3.4%), F. solani (1.7%), and C. globosum (1.7%). 
However, several studies reported that S. brevicaulis was 
more frequently isolated than Aspergillus species
6,7,25. 
Presently, of Aspergillus species, A. niger was most 
frequently isolated (25.6%), which coincides well with the 
results of previous studies
5-7, followed by A. fumigatus 
(25.4%),  A. flavus (15.3%), A. terreus (5.1%), and A. 
sydowii (1.7%). F. solani was also isolated in our patients. 
Tosti et al.
2 have shown that the incidence of 
onychomycosis due to Fusarium species, such as F. solani 
and  F. oxysporum, are increasing. C. globosum was 
isolated by analyzing the base sequence of the ITS region, 
as has been done previously
30. In Aspergillus species, 
especially  A. niger and S. brevicaulis, PSO was more 
frequently found. Similarly, Tosti et al.
2 reported that PSO 
is more common in the Aspergillus species, S. brevicaulis, 
and Fusarium species. 
In summary, patients with onychomycosis due to NDM 
accounted for a larger proportion of those with onycho-
mycosis. In addition, various causative organisms of 
onychomycosis due to NDM were isolated in our patients. 
The results of this study suggest that further laboratory 
tests should be performed on patients with onycho-
mycosis in order to identify NDM. 
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